In today’s recent session, 0.53 million shares of the Neumora Therapeutics Inc (NASDAQ:NMRA) have been traded, and its beta is 2.44. Most recently the company’s share price was $2.10, and it changed around $0.04 or 1.98% from the last close, which brings the market valuation of the company to $339.41M. NMRA at last check was trading at a discount to its 52-week high of $21.00, offering almost -900.0% off that amount. The share price’s 52-week low was $1.83, which indicates that the recent value has risen by an impressive 12.86% since then. We note from Neumora Therapeutics Inc’s average daily trading volume that its 10-day average is 5.25 million shares, with the 3-month average coming to 2.79 million.
Neumora Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.44. If we narrow it down even further, the data shows that 0 out of 10 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 2 recommended NMRA as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Neumora Therapeutics Inc is expected to report earnings per share of -0.37 for the current quarter.
Neumora Therapeutics Inc (NASDAQ:NMRA) trade information
Instantly NMRA has been showing a green trend so far today with a performance of 1.98% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.32 on recent trading dayincreased the stock’s daily price by 9.48%. The company’s shares are currently down -80.18% year-to-date, but still down -7.86% over the last five days. On the other hand, Neumora Therapeutics Inc (NASDAQ:NMRA) is -79.36% down in the 30-day period. We can see from the shorts that 12.99 million shares have been sold at a short interest cover period of 13.99 day(s).
The consensus price target as assigned by Wall Street analysts is $4, which translates to bulls needing to increase their stock price by 47.5% from its current value. Analyst projections state that NMRA is forecast to be at a low of $4 and a high of $4.
Neumora Therapeutics Inc (NMRA) estimates and forecasts
Neumora Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -81.91 percent over the past six months and at a 55.65% annual growth rate that is well above the industry average of 16.50%.
Forecasts for the next quarter put sales growth at 0.00%.
NMRA Dividends
Neumora Therapeutics Inc’s next quarterly earnings report is expected to be released in February.
Neumora Therapeutics Inc (NASDAQ:NMRA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 27.47% of Neumora Therapeutics Inc shares, and 66.34% of them are in the hands of institutional investors. The stock currently has a share float of 91.47%.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Sep 30, 2024. The former held 2.39 shares worth $5.0 million, making up 1.48% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 2.16 shares worth around $4.52 million, which represents about 1.34% of the total shares outstanding.
